paclitaxel

Type: Keyphrase
Name: paclitaxel
First reported 12 hours ago - Updated 19 mins ago - 1 reports

Forum Post: Side effects to chemo

Hi all haven't been on for a while. In my 3 rd cycle of carboplatin and paclitaxel. Find there is a definite pattern to my cycles. However by day 7 through to day 11/12 I am getting alot of breathless on doing everyday chores. If I walk the dog I find ... [Published Macmillan Cancer Support - 12 hours ago]
First reported 2 hours ago - Updated 2 hours ago - 1 reports

Novocure™ Enrolls First Patient in a Pilot Study of Tumor Treating Fields (TTFields) Together with Paclitaxel for the Treatment of Recurrent Ovarian Cancer

ST. HELIER, Jersey, Oct. 30, 2014 /PRNewswire/ -- Novocure announced today that the first patient has been enrolled in the INNOVATE study, an open-label pilot clinical study of TTFields together with weekly paclitaxel for patients with recurrent ovarian ... [Published PR Newswire: Health - 2 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

ESMO: Cancer Immunotherapy on the Road

Since cancer immunotherapy was declared the Breakthrough of the Year in 2013 by Science magazine the field has been on fire, and its relatively few experts have been on the run– explaining the nascent technology and related data to oncologists at venues ... [Published Drug Discovery and Development - 21 hours ago]
First reported Oct 27 2014 - Updated Oct 27 2014 - 1 reports

Computational identification of multi-omic correlates of anticancer therapeutic response

A challenge in precision medicine is the transformation of genomic data into knowledge that can be used to stratify patients into treatment groups based on predicted clinical response. Although clinical trials remain the only way to truly measure drug ... [Published 7thSpace - Oct 27 2014]
First reported Oct 27 2014 - Updated Oct 27 2014 - 1 reports

Erie hospital treats leg blockages with drug-coated balloon

Saint Vincent Hospital cardiologist Matthew "Casey" Becker, M.D., held up an uninflated balloon attached to a long, flexible wire.The balloon was nearly 8 inches long, and Becker was about to guide it through a patient's femoral artery and down into his ... [Published Erie Times-News - Oct 27 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Correspondence: from balloons to stents and back again?

October 2014 Volume 21, Issue 4 Br J Cardiol 2014;21:(4) Authors:Drs Usha Rao and Simon C EccleshallCorrespondence from the world of cardiologyDear Sirs,Ischaemic heart disease (IHD) is a major cause of mortality and morbidity, and percutaneous coronary ... [Published British Journal of Cardiology - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Olaparib tablet shows promise in pretreated ovarian cancer

Oral olaparib tablets combined with a weekly regimen of carboplatin and paclitaxel was safe for use in patients with advanced ovarian cancer who have failed to respond to first-line therapy, according to early preliminary data.“This study is one of the ... [Published Orthopedics Today - Oct 23 2014]
First reported Oct 20 2014 - Updated Oct 21 2014 - 2 reports

Trastuzumab continues to show life for HER2-positve early stage breast cancer

PUBLIC RELEASE DATE: 20-Oct-2014JACKSONVILLE, Fla. — After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free survival ... [Published EurekAlert! - Oct 20 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

Studies from Sichuan University Provide New Data on Paclitaxel Therapy (Targeted Paclitaxel Delivery to Tumors Using Cleavable PEG-Conjugated Solid...

Studies from Sichuan University Provide New Data on Paclitaxel Therapy (Targeted Paclitaxel Delivery to Tumors Using Cleavable PEG-Conjugated Solid Lipid Nanoparticles)By a News Reporter-Staff News Editor at Biotech Week Data detailed on Drugs and Therapies ... [Published Pharmacy Choice - Oct 15 2014]
First reported Oct 14 2014 - Updated Oct 14 2014 - 2 reports

Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug ...

Taxanes such as paclitaxel and docetaxel are used successfully to treat breast cancer, usually in combination with other agents. They interfere with microtubules causing cell cycle arrest; however, the mechanisms underlying the clinical effects of taxanes ... [Published 7thSpace - Oct 14 2014]
First reported Oct 10 2014 - Updated Oct 11 2014 - 3 reports

C.R. Bard scores FDA approval for Lutonix 035 Drug Coated Balloon

C. R. Bard (Murray Hill, New Jersey) reported FDA approval of the Lutonix 035 Drug Coated Balloon (DCB) catheter for percutaneous transluminal angioplasty (PTA), after pre-dilatation, for the treatment of de novo or restenotic lesions up to 150mm in length ... [Published Medical Device Daily - Oct 10 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 3 reports

Phyton Biotech Launches New Website

) - Phyton Biotech, the pioneer in plant cell fermentation (PCF®) technology with the world's largest capacity for paclitaxel and docetaxel API via PCF, has launched a new website: www.phytonbiotech.com .The new website maintains Phyton's commitment to ... [Published Reliance Trust - Oct 07 2014]

Quotes

...erformance for key products including Eliquis, Yervoy, Sprycel and Orencia," said Lamberto Andreotti, chief executive officer, Bristol-Myers Squibb. "We continue to build a solid foundation for our future as a Diversified Specialty BioPharma by advancing our own R&D efforts and investing in strategic business development to build a sustainable pipeline."
...delivered outstanding third quarter results setting up a strong finish to 2014," said Bob Hugin, chairman and chief executive of Celgene, adding: "Upcoming US and European clinical and regulatory milestones and the meaningful progress we are making with our pipeline strengthen our position for future growth and success."
The study is published in the Proceedings of the National Academy of Sciences titled, "Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing."
Study HM-OTE-103, entitled "A Phase I Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety of Oratecan in Combination with Capecitabine in Patients with Advanced Solid Cancer" was conducted at two clinical sites in South Korea...

More Content

All (280) | News (241) | Reports (0) | Blogs (32) | Audio/Video (0) | Fact Sheets (4) | Press Releases (1)
sort by: Date | Relevance
Novocure™ Enrolls First Patient in a Pilot Stud... [Published PR Newswire: Health - 2 hours ago]
Forum Post: Side effects to chemo [Published Macmillan Cancer Support - 12 hours ago]
Drug-eluting balloon angioplasty shows excellen... [Published Diagnostic & Invasive Cardiology - 15 hours ago]
ESMO: Cancer Immunotherapy on the Road [Published Drug Discovery and Development - 21 hours ago]
Delivering a patient-centred high-quality homec... [Published Nursing Times - Oct 29 2014]
Neoadjuvant Therapy of Early Stage Human EGFR 2... [Published General Medicine eJournal - Oct 29 2014]
Bristol-Myers Squibb Posts Third Quarter Results [Published Individual.com - Oct 29 2014]
Bristol-Myers Squibb Releases 3Q 2014 Financial... [Published Individual.com - Oct 29 2014]
Dyax's (DYAX) CEO Gustav Christiansen on Q3 201... [Published Seeking Alpha - Oct 29 2014]
Pulmonary Hypertension Linked to Lack of Transc... [Published Genetic Engineering News - Oct 28 2014]
Targeting NSCLC Through Molecular Markers [Published American Journal of Managed Care - Oct 27 2014]
Celgene third-quarter results beat estimates; u... [Published Pharma Letter - Oct 27 2014]
Computational identification of multi-omic corr... [Published 7thSpace - Oct 27 2014]
Researchers Discover Possible “Off-Switch” To H... [Published Bioresearch Online - Oct 27 2014]
Hanmi Pharmaceuticals and Collaborative Partner... [Published Pharmacy Choice - Oct 27 2014]
Erie hospital treats leg blockages with drug-co... [Published Erie Times-News - Oct 27 2014]
C R Bard : FDA OKs Lutonix 035 Drug Coated Balloon [Published 4 Traders - Oct 25 2014]
Bristol-Myers Squibb Reports Third Quarter 2014... [Published Scottrade - Oct 24 2014]
New drug could help in battle against cervical ... [Published Manufacturing Chemist - Oct 24 2014]
Celgene signs $1bn immunotherapy collaboration ... [Published PMLive - Oct 24 2014]
Verastem Presents New Data on Mesothelioma Prog... [Published Scottrade - Oct 24 2014]
Verastem Presents New Data on Mesothelioma Prog... [Published Pettinga Financial Advisors - Oct 24 2014]
ESO-ESMO Consensus Guidelines for Advanced Brea... [Published General Medicine eJournal - Oct 24 2014]
Eli Lilly and's (LLY) CEO John Lechleiter on Q3... [Published Seeking Alpha - Oct 24 2014]
Correspondence: from balloons to stents and bac... [Published British Journal of Cardiology - Oct 23 2014]
Celgene Reports Third Quarter 2014 Operating an... [Published Scottrade - Oct 23 2014]
Olaparib tablet shows promise in pretreated ova... [Published Orthopedics Today - Oct 23 2014]
Sorrento Therapeutics : Initial Pharmacokinetic... [Published 4 Traders - Oct 23 2014]
Research suggests there may be an off switch fo... [Published Gizmag - Oct 22 2014]
Lifespan Based Pharmacokinetic-Pharmacodynamic ... [Published Plosone.org - Oct 21 2014]
1 2 3 4 5 6 7 8 9 10
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Novocure™ Enrolls First Patient in a Pilot Stud... [Published PR Newswire: Health - 2 hours ago]
ST. HELIER, Jersey, Oct. 30, 2014 /PRNewswire/ -- Novocure announced today that the first patient has been enrolled in the INNOVATE study, an open-label pilot clinical study of TTFields together with weekly paclitaxel for patients with recurrent ovarian ...
Quackademic medicine in Connecticut [Respectful... [Published ScienceBlogs : Combined Feed - Oct 14 2014]
A common topic that I’ve written about since the very beginning of this blog is the infiltration of quackery into what were formerly bastions of science-based medicine. Most recently, I lamented just how far this process has progressed at the Cleveland ...
Phyton Biotech Launches New Website [Published Marketwire - Breaking News Releases - Oct 07 2014]
VANCOUVER, BC--(Marketwired - October 07, 2014) - Phyton Biotech, the pioneer in plant cell fermentation (PCF®) technology with the world's largest capacity for paclitaxel and docetaxel API via PCF, has launched a new website: www.phytonbiotech.com ...
Biothera to Present Late-Breaking Data from Its... [Published Business Wire Health News - Sep 28 2014]
EAGAN, Minn.--(BUSINESS WIRE)--Biothera will present today results on its investigational immunotherapy Imprime PGG® in combination with standard of care frontline chemotherapy and bevacizumab in patients with stage IV nonsquamous non-small cell lung ...
Celgene Announces the Swissmedic Approval of AB... [Published Business Wire Health News - Sep 24 2014]
BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that Swissmedic, the regulatory authority for Switzerland, has granted approval for ABRAXANE® (paclitaxel ...
1 2 3 4 5 6 7

Press Releases

sort by: Date | Relevance
Oasmia’s Lead Human Product Paclical® Successfu... [Published GlobeNewswire: Acquisitions News - Jun 16 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.